ABILIFY cpr 30 mg 28 pce
7680562090249
CH-56209
N05AX12
01.05.0.
1 / 3
google
Details
- Product number
- 5620903
- CPT
- -
- Packaging group
- 28
- Unit
- Tablette(n)
- Composition
- aripiprazolum 30 mg, lactosum monohydricum 186.54 mg, maydis amylum, cellulosum microcristallinum, hydroxypropylcellulosum, magnesii stearas, aqua purificata, E 172 (rubrum) pro compresso.
Articles (1)
Abilify 30 mg, Tabletten
Tabletten
28
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
30.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
186.54 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
Reimbursement information
Public price
CHF 126.65
Specialties list
Yes
Generic
No
SL addition date:
01/12/2004
Authorization holder
Otsuka Pharmaceutical
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 56209
- Drug name
- Abilify, Tabletten
- Galenic form
- TAB
- ATC Code
- N05AX12
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 08/06/2004
- Authorization expiration date
- 31/12/9999
- IT number
- 01.05.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ABILIFY cpr 30 mg 28 pce
- Description (DE)
- ABILIFY Tabl 30 mg 28 Stk
- Market launch
- 05/08/2004
- Narcotic (BTM)
- No